Core Insights - Altria's annual profit forecast is significantly below market expectations due to decreased demand for cigarettes and oral smoking alternatives like on! nicotine pouches [1] Company Summary - Altria is experiencing lower demand for its traditional cigarette products and newer oral smoking alternatives, which is impacting its profitability outlook [1] Industry Summary - The tobacco industry is facing challenges with declining demand for traditional smoking products, indicating a potential shift in consumer preferences towards healthier alternatives [1]

Financial Performance - Net revenues for the nine months ended September 30, 2025, were $17,433 million, a decrease of 3.4% from $18,044 million in the same period of 2024[15]. - Gross profit for the nine months ended September 30, 2025, was $10,911 million, compared to $10,763 million for the same period in 2024, reflecting a slight increase of 1.3%[15]. - Net earnings for the nine months ended September 30, 2025, were $5,830 million, down 29.1% from $8,225 million in the same period of 2024[15]. - Basic and diluted earnings per share for the nine months ended September 30, 2025, were $3.45, compared to $4.75 for the same period in 2024, representing a decrease of 27.7%[15]. - Operating income for the nine months ended September 30, 2025, was $8,248 million, slightly down from $8,359 million in 2024[87]. - Earnings before income taxes for the nine months ended September 30, 2025, were $7,876 million, a decline of 27.5% compared to $10,881 million in 2024[102]. - For the nine months ended September 30, 2025, reported net earnings decreased by 29.1% to $5.83 billion, and diluted EPS decreased by 27.4% to $3.45 compared to the same period in 2024[208]. - Adjusted net earnings for the same period increased by 3.6% to $6.97 billion, while adjusted diluted EPS rose by 5.9% to $4.12 compared to 2024[208]. Assets and Liabilities - Total current assets increased to $5,119 million as of September 30, 2025, from $4,513 million as of December 31, 2024, marking a growth of 13.4%[10]. - Total liabilities increased to $37,604 million as of September 30, 2025, compared to $37,365 million as of December 31, 2024, an increase of 0.6%[12]. - The carrying value of the company's total long-term debt was $25.7 billion as of September 30, 2025, compared to $24.9 billion at December 31, 2024[73]. - The current portion of long-term debt rose to $1,569 million as of September 30, 2025, from $1,527 million as of December 31, 2024, an increase of 2.8%[12]. - The total stockholders' equity (deficit) attributable to Altria was $(2,646) million as of September 30, 2025, compared to $(2,238) million as of December 31, 2024[12]. Cash Flow and Investments - Cash provided by operating activities for the nine months ended September 30, 2025, was $6,019 million, compared to $5,413 million in 2024, indicating an increase of about 11.2%[24]. - Total cash, cash equivalents, and restricted cash at the end of September 2025 amounted to $3,496 million, an increase from $3,158 million at the beginning of the period[27]. - The company repurchased $712 million worth of common stock in the nine months ended September 30, 2025, at an average price of $58.08 per share[37]. - The net cash used in investing activities for the nine months ended September 30, 2025, was $(139) million, compared to $2,238 million in 2024[26]. - The company experienced losses from investments in equity securities amounting to $(398) million for the nine months ended September 30, 2025[24]. Dividends and Shareholder Returns - Cash dividends declared were $3.10 per share for the nine months ended September 30, 2025, totaling $5,231 million[19]. - The company declared cash dividends of $1.06 per share in August 2025, up from $1.02 per share, marking a 3.9% increase[33]. Legal and Regulatory Matters - The company recorded pre-tax charges of $44 million for tobacco and health litigation for the nine months ended September 30, 2025[115]. - PM USA has paid approximately $1.1 billion in judgments and settlements since October 2004, with interest totaling approximately $246 million as of September 30, 2025[116]. - The number of individual smoking and health cases pending against the company increased to 181 as of October 27, 2025, from 167 a year earlier[119]. - In October 2025, a jury awarded $1 million in compensatory damages and $5.5 million in punitive damages against PM USA and R.J. Reynolds in the Perez-Trinidad case[125]. - PM USA is named as a defendant in seven class actions filed in Canadian provinces, with a global settlement amount of CAD $32.5 billion agreed upon by other tobacco manufacturers[141]. Market Trends and Consumer Behavior - The discount share of the cigarette category reached 32.2% in Q3 2025, an increase of 2.4 share points from Q3 2024, indicating a shift in consumer preferences[202]. - Estimated domestic cigarette industry volume declined by 8% in Q3 2025 compared to Q3 2024, with PM USA's domestic cigarette shipment volume declining by an estimated 9%[202]. - The U.S. nicotine pouch category grew to 55.7% of the U.S. oral tobacco category, an increase of 11.1 share points from Q3 2024[202]. - Inflationary pressures on discretionary income have constrained consumer spending, particularly affecting lower-income tobacco consumers[201]. - Flavored disposable e-vapor products represent over 60% of the e-vapor category, with regulatory actions being taken against illicit products[204]. Strategic Initiatives - The company expects to complete the design and detailed plans for the Optimize & Accelerate initiative by early 2026, aiming to enhance organizational efficiency[56]. - Total pre-tax charges for the Optimize & Accelerate initiative are estimated to be approximately $125 million, with $111 million incurred as of September 30, 2025[57].

Exhibit 99.1 ALTRIA REPORTS 2025 THIRD-QUARTER AND NINE-MONTHS RESULTS; ANNOUNCES EXPANDED SHARE REPURCHASE PROGRAM; NARROWS 2025 FULL-YEAR EARNINGS GUIDANCE RICHMOND, Va. - October 30, 2025 - Altria Group, Inc. (NYSE: MO) today reports our 2025 third-quarter and nine-months business results, announces the expansion of our existing share repurchase program and narrows our guidance for 2025 full-year adjusted diluted earnings per share (EPS). "Altria continued to build significant momentum in the third quart ...

Core Insights - Altria Group, Inc. and Philip Morris International Inc. are navigating a transforming tobacco market with distinct strategies, focusing on smoke-free alternatives and maintaining strong brand presence [1][2] Altria Group, Inc. - Altria's pricing power is a key factor in its financial resilience, with a 10% net price realization in smokeable products leading to a 4.2% increase in adjusted operating companies income (OCI) in Q2 2025 [6] - The oral tobacco segment, particularly the on! nicotine pouch brand, saw shipments rise 26.5% year over year, contributing to a 10.9% increase in adjusted OCI [7] - Adjusted earnings per share (EPS) increased 8.3% year over year to $1.44 in Q2 2025, with revenues net of excise taxes at $5.29 billion [8] - Marlboro maintains a 59.5% share in the premium category, showcasing Altria's strong market position and ability to adapt to a smoke-free future [10] Philip Morris International Inc. - Philip Morris's growth is driven by smoke-free products, which accounted for 41% of total net revenues and 42% of gross profit in Q3 2025 [11] - Shipments of IQOS, ZYN, and VEEV showed significant growth, with IQOS shipments up 15.5% to 41 billion units, maintaining a 76% global share in heated tobacco [12] - Adjusted operating income rose 12.4% to $4.7 billion, with adjusted EPS increasing 17.3% to $2.24, supported by strong performance in smoke-free products [13] - Despite a 3.2% decline in cigarette shipment volumes, Philip Morris managed a 4.3% increase in net revenues through pricing strategies [14] Market Performance - Altria's stock has gained 25.3% over the past year, outperforming Philip Morris's 13.1% increase and the broader S&P 500's 20.6% rise [21] - Altria is trading at a forward P/E ratio of 11.41, while Philip Morris's forward P/E ratio stands at 18.24 [20] Investment Outlook - Altria is positioned as a better investment for income-focused investors due to its attractive valuation, robust pricing power, and growing smoke-free momentum, while Philip Morris offers stronger global growth potential [22]

Core Viewpoint - Altria Group, Inc. is set to report its third-quarter 2025 earnings on October 30, with expected revenues of $5.32 billion, reflecting a 0.4% decline year-over-year, while earnings per share are projected to grow by 4.4% to $1.44 [1][5] Earnings Performance - Altria has a trailing four-quarter average earnings surprise of 3.3%, with the last quarter's earnings exceeding the Zacks Consensus Estimate by 5.1% [2] - The current Zacks Rank for Altria is 2 (Buy), but it has an Earnings ESP of -0.04%, indicating uncertainty regarding an earnings beat this quarter [3][4] Factors Influencing Q3 Earnings - Strong pricing power, disciplined cost management, and momentum in smoke-free initiatives are expected to drive Q3 results [5] - Volume softness in traditional cigarettes is noted due to inflationary pressures, but robust pricing actions and strategic portfolio management are anticipated to offset this weakness [5] Key Growth Drivers - The high-margin oral tobacco business, particularly the growth of on! nicotine pouches, is a significant contributor to earnings resilience [6] - Continued consumer engagement through marketing efforts is expected to enhance brand equity and repeat usage [6][8] Stock Performance - Over the past three months, Altria's stock has increased by 7.4%, outperforming the Zacks Tobacco industry's breakeven performance and the Consumer Staples sector's decline of 3.6% [7] - Compared to competitors, Altria has outperformed Philip Morris International and British American Tobacco, while underperforming Turning Point Brands [7] Valuation Analysis - Altria shares are trading at a forward 12-month price-to-earnings ratio of 11.49, below the industry average of 14.49, indicating compelling value for investors [9] - The valuation gap is notable when compared to competitors, with Philip Morris at 18.66 and Turning Point Brands at 23.94 [11] Investment Outlook - Altria's strong pricing strategies and expansion of smoke-free products, particularly on! nicotine pouches, position the company as an attractive investment option [12] - With steady earnings growth and solid cash flow, Altria is viewed as a reliable choice for stability and long-term returns in the consumer staples sector [12]

Core Insights - Altria (MO) is expected to report quarterly earnings of $1.44 per share, reflecting a 4.4% increase year-over-year, while revenues are forecasted at $5.32 billion, indicating a 0.4% decline compared to the previous year [1] - Analysts have revised the consensus EPS estimate down by 0.3% over the last 30 days, suggesting a reevaluation of initial estimates by analysts [1][2] Revenue Estimates - Revenues net of excise taxes for Oral tobacco products are projected to be $713.65 million, showing a year-over-year increase of 2.7% [4] - Revenues net of excise taxes for Smokeable Products are expected to reach $4.64 billion, reflecting a slight decline of 0.2% from the same quarter last year [4] Operating Income Estimates - Operating Income for Oral tobacco products is estimated at $486.18 million, compared to $464.00 million from the previous year [5] - Adjusted Operating Income for Smokeable Products is anticipated to be $3.00 billion, up from $2.94 billion reported in the same quarter last year [5] Stock Performance - Altria shares have decreased by 1.6% over the past month, contrasting with a 2.5% increase in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the overall market in the near term [5]

Group 1: Altria Group Inc. (MO) - Altria Group has a dividend yield of 6.5% and has increased its dividend 60 times over the past 56 years, making it an attractive option for dividend investors [5][6] - Despite a declining cigarette volume market, which saw a 6% annual decline from 2019 to 2024, Altria continues to generate strong cash flow and expanding margins [4][9] - The U.S. tobacco market remains stable at around $90 billion, allowing for price increases that can offset volume declines, positioning Altria for potential growth [6][10] Group 2: Conagra Brands (CAG) - Conagra Brands primarily operates in the U.S. frozen food market with well-known brands but faces challenges due to lower investment in product development and marketing [12][14] - The company's previous acquisition strategy has not yielded positive results, as evidenced by the divestment of Ralcorp at half the purchase price [13] - Conagra's focus on brand building is commendable, but without significant investment in marketing and innovation, it risks falling behind competitors in a highly competitive market [15][16] Group 3: Comparative Analysis - Altria is successfully expanding margins and increasing free cash flow, while Conagra struggles to invest in its brands, leading to stagnant growth [18][19] - The contrasting performance of these two companies highlights that not all dividend stocks are equally positioned for long-term success [18]

Core Points - The construction of a new 90,000 square foot ballroom at the White House is projected to cost $300 million, with funding coming from Big Tech and other corporate donors, contrary to earlier promises that the East Wing would remain untouched [2][5]. - Alphabet is contributing $22 million, approximately 7% of the total project cost, as part of a settlement related to a lawsuit involving YouTube [4][5]. - A list of corporate donors includes major companies such as Amazon, Apple, Microsoft, and Meta, among others [3][6]. Funding Details - The ballroom's funding will come from corporate and individual donors, with no taxpayer money involved [2][3]. - The White House has disclosed a list of donors, which includes companies like Lockheed Martin, Palantir, and Coinbase, as well as various foundations and individual contributors [5][6][8]. - Comcast is also listed as a donor, although the exact amount of their contribution is unclear [6][7]. Project Background - The initial cost estimate for the ballroom was $200 million, which has now increased to $300 million [2]. - The project has faced public backlash due to the demolition of the East Wing, which was previously promised to remain intact [2].

Summary of Ispire Technology Conference Call Company Overview - **Company Name**: Ispire Technology Inc. (NasdaqCM:ISPR) - **Industry**: Nicotine and Cannabis Hardware Solutions - **Headquarters**: Los Angeles, California - **Global Operations**: Factories located in Shenzhen, China, and Johor, Malaysia, serving over 30 countries [1][2] Core Business and Market Position - **Product Offerings**: - Open and closed system nicotine vaping products - Custom devices for cannabis oils - Proprietary age-gating technology through a joint venture called IKE Tech [2][4][5] - **Historical Context**: Founded by Tony Liu, a pioneer in the e-cigarette industry, with a significant market presence prior to JUUL's rise [2][3] Financial Performance - **Revenue Breakdown**: Majority of revenue from North America and Europe, with a significant portion from cannabis products [3][4] - **Manufacturing Strategy**: Transitioning to in-house manufacturing in Malaysia to increase gross margins by 15% to 20% [10] Technological Innovations - **Age-Gating Technology**: - Bluetooth and blockchain-based system for verifying user age before activating vaping devices - PMTA submitted for FDA approval, with acceptance received within 28 days [5][7][19] - **New Product Developments**: - Ispire One: A self-sealing vape technology that simplifies the filling process [12] - GMASH atomizer technology: Designed for better nicotine absorption through smaller particle sizes [14][15] Market Trends and Regulatory Environment - **Regulatory Landscape**: - Current U.S. market heavily regulated, with only menthol and tobacco-flavored vapes approved - Significant illicit market presence, with only 20% of vapes sold legally [18] - **Future Outlook**: - Anticipation of increased demand for flavored vapes as age-gating technology is adopted - Potential for expansion into Southeast Asia and Middle Eastern markets [8][19] Competitive Landscape - **Market Fragmentation**: No dominant brand in the global vaping market, with many products imported from China [17] - **Intellectual Property Strategy**: Development of products that avoid infringing on JUUL's extensive patent portfolio [20][21] Cannabis Sector Involvement - **Current Position**: Active in the cannabis vaping market, focusing on high-quality legacy customers [26] - **Financial Strategy**: Shifted to requiring upfront payments from customers to stabilize accounts receivable [27] Management Team - **Leadership**: - Tony Liu, founder and innovator in e-cigarette technology - Experienced management team with a focus on product quality and technological advancement [28][29] Conclusion - **Growth Potential**: Ispire Technology is well-positioned to capitalize on the growing nicotine vaping market, driven by innovative technologies and a strategic manufacturing approach. The company aims to address regulatory challenges and market demands through its proprietary solutions and partnerships with major tobacco companies [16][22][23]

Core Insights - Altria Group, Inc.'s long-term earnings strategy focuses on smart reinvestment of cost savings to fuel growth rather than just cutting costs [1][2] - The company aims for a smoke-free future, directing savings towards smoke-free product development and regulatory preparation [2] - Management's guidance for 2025 adjusted earnings per share is between $5.35 and $5.45, indicating a growth of 3% to 5% from the previous year [1][8] Financial Performance - In Q2 2025, Altria's smokeable products segment margin increased to 64.5%, indicating early signs of efficiency improvements [3] - The Zacks Consensus Estimate for Altria's 2025 and 2026 earnings suggests year-over-year growth of 6.1% and 2.6%, respectively [11] - Altria's shares have decreased by 1.8% over the past month, while the industry has seen a decline of 5.5% [7] Competitive Landscape - Philip Morris International Inc. is successfully driving earnings growth through investments in its smoke-free portfolio, leading to margin expansion and an upgraded earnings forecast [5] - Turning Point Brands, Inc. reported a 651% year-over-year sales increase in the modern oral category, contributing to a nearly 14.8% rise in adjusted EBITDA [6] Valuation Metrics - Altria trades at a forward price-to-earnings ratio of 11.5X, lower than the industry's average of 14.06X [10]